Eliot Berson, M.D., of Mass. Eye and Ear and Harvard Medical School, receives Visionary Award from Foundation Fighting Blindness
Eliot Berson, M.D., of Mass. Eye and Ear and Harvard Medical School, Receives Visionary Award from Foundation Fighting Blindness
BOSTON (June 29, 2012) – Eliot L. Berson, M.D., director of the Berman-Gund Laboratory for the Study of Retinal Degenerations located at the Mass. Eye and Ear, recently received the Foundation Fighting Blindness Visionary Award. Mr. Gordon Gund, Chairman of the Maryland-based Foundation Fighting Blindness, presented Dr. Berson with the award at the foundation’s “Dining in the Dark” event on Thursday, June 21 at the Boston InterContinental Hotel.
Other recipients awarded include Massachusetts Governor Deval L. Patrick and Joshua S. Boger, Ph.D., founder of Vertex Pharmaceuticals, an international company headquartered in Cambridge, Mass. Mass. Eye and Ear President and CEO John Fernandez attended the event.
The Visionary Award was presented to Dr. Berson for his important role in research to advance the understanding of potentially blinding diseases and for the development of the first treatment for retinitis pigmentosa.
“Our studies have led to a better understanding of the causes of hereditary retinal degenerations at the DNA level and also have led to the first treatment for the common forms of retinitis pigmentosa. We have found that a high-dose of vitamin A combined with an oily fish diet and lutein will, on average, extend vision for up to 20 additional years, thereby making it possible for many patients with retinitis pigmentosa to see for their entire lives. We were also the first to show that high-dose vitamin E supplementation aggravates the course of these diseases,” said Dr. Berson during his speech.